Evaxion A/S: Financial statements 2019
CVR: 31762863
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Evaxion A/S (CVR 31762863) has filed annual accounts for 2019. In 2019, the company reported a net result of USD -10,814,000 compared with DKK -17,060,437 the year before. Equity in the 2019 report amounted to USD 9,273,000. The solvency ratio was 83.8%.
- Profit/Loss
- USD -10,814,000
- Equity
- USD 9,273,000
- Total Assets
- USD 11,070,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -10.8 mio. USD | 9.3 mio. USD | - |
| 2018 | - | -8.4 mio. | -17.1 mio. | 38.4 mio. | 18 |
| 2017 | - | -4.5 mio. | -10.4 mio. | 15.8 mio. | 13 |
| 2016 | - | -524 t. | -5 mio. | 10 mio. | 14 |
| 2015 | - | -5.1 mio. | -6 mio. | 13 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of July 19, 2019, Jo Ann Suzich has joined the board of directors of Evaxion A/S.
Evaxion A/S has published its annual report for 2018. Gross profit came to DKK -8,390,221, and the net result was DKK -17,060,437.
On March 29, 2019, the company changed its name from EVAXION BIOTECH ApS to EVAXION BIOTECH A/S.
About Evaxion A/S
Evaxion A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EVAXION BIOTECH A/S and EVAXION BIOTECH ApS. The management consists of Helen Katrina Tayton-Martin, Andreas Holm Mattsson and Thomas Frederik Schmidt. The board consists of Marianne Søgaard (chair), Jens Bitsch-Nørhave, Lars Holtug and Lars Aage Staal Wegner. The company is owned by BNY (Nominees) Limited (as nominee of The Bank of New York Mellon). The company has 44 employees (2026). In 2025, the company reported revenue of DKK 48,112,000 and a net result of DKK -51,489,000 compared with DKK -73,277,000 the year before. Equity in the 2025 report amounted to DKK 108,250,000.